Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Tibolon-Mepha"
<
Preisvergleich für Lodotra 5 mg
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Registr. Holder
Package Size
Composition
CP
%
SB
DC
IP
CI
Lodotra 5 mg
Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch
100 Tablette(n)
: Prednisonum 5 mg
86.50
10 %
IP
CI
Prednison Axapharm 5 mg
axapharm ag
100 Tablette(n)
Tabletten: Prednisonum 5 mg
16.75
-80%
10 %
IP
CI
Prednison Galepharm 5 mg
Galepharm AG
100
Tabletten: Prednisonum 5 mg
16.75
-80%
10 %
IP
Prednison Spirig HC 5 mg
Spirig HealthCare AG
100
Tabletten: Prednisonum 5 mg
16.75
-80%
10 %
IP
CI
Prednison Stada 5 mg
Spirig HealthCare AG
100
Tabletten: Prednisonum 5 mg
16.75
-80%
k.A.
IP
CI
Prednison Streuli 5 mg
Streuli Pharma AG
100 Tablette(n)
Tabletten: Prednisonum 5 mg
16.90
-80%
10 %
IP
CI
Galpred 5 mg
Galepharm AG
100
Tabletten: Prednisonum 5 mg
PR
k.A.
For price comparison between Original and Generic please click onto the name of the drug all the way to the left!
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
